Xeris Pharmaceuticals Inc (XERS) stock is lower by -42.41% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives XERS stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a long-term technical score of 2. XERS's rank also includes a short-term technical score of 5. The fundamental score for XERS is 95. In addition to the average rating from Wall Street analysts, XERS stock has a mean target price of $9.00. This means analysts expect the stock to increase 224.91% over the next 12 months.
XERS has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on XERS!
Xeris Pharmaceuticals Inc (XERS) stock has risen 0.36% while the S&P 500 has risen 0.16% as of 10:36 AM on Wednesday, Sep 1. XERS has risen $0.01 from the previous closing price of $2.76 on volume of 285,984 shares. Over the past year the S&P 500 is higher by 28.45% while XERS is lower by -42.41%. XERS lost -$1.47 per share in the over the last 12 months.
Click Here to get the full Stock Report for Xeris Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
